IDV vehicle
36E79725D0014
NEW AWARD FOR PEGFILGRASTIM WITH COHERUS BIOSCIENCES, INC. ORDERING PERIOD IS APRIL 11, 2025, TO APRIL 10, 2026, WITH FOUR ONE-YEAR OPTIONS.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $27.6M |
| Start date | Apr 11, 2025 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Sep 2, 2026 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 8 of 8 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 2, 2026 | P00007 | $0 | IMPLEMENTING EO 14398 DEI DISCRIMINATION |
| Apr 14, 2026 | P00005 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE AN NDC ADDITION AND DELETION INTO NATIONAL CONTRACT 36E79725D0014. |
| Apr 14, 2026 | P00006 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE ACCORD BIOPHARMA INC'S 2026 SUBCONTRACTING PLAN FOR THE PERIOD OF APRIL 1, 2026 TO MARCH 31, 2027 INTO NATIONAL CONTRACT 36E79725D0014. |
| Mar 17, 2026 | P00004 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE A NOVATION AGREEMENT INTO NATIONAL CONTRACT 36E79725D0014. |
| Mar 10, 2026 | P00003 | $0 | THIS MODIFICATION IS ISSUED TO EXERCISE OPTION YEAR 1 ON NC 36E79725D0014 WITH A PERIOD OF PERFORMANCE OF 4/11/2026 TO 4/10/2027. |
| Feb 5, 2026 | P00002 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE AN NDC ADDITION INTO NC 36E79725D0014. |
| Nov 21, 2025 | P00001 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE 2026 FEDERAL CEILING PRICES FOR NC 36E79725D0014. |
| Jan 23, 2025 | 0 | $0 | NEW AWARD FOR PEGFILGRASTIM WITH COHERUS BIOSCIENCES, INC. ORDERING PERIOD IS APRIL 11, 2025, TO APRIL 10, 2026, WITH FOUR ONE-YEAR OPTIONS. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.